优化基于 919 株的牛附红细胞体热病毒疫苗(Ultravac®,Zoetis™)的接种方案:剂量依赖性有效性和长期免疫力评估。

IF 4.5 3区 医学 Q2 IMMUNOLOGY
Dan Gleser , Michal Cohen , Gabriel Kenigswald , Maor Kedmi , Benny Sharir , Eyal Klement
{"title":"优化基于 919 株的牛附红细胞体热病毒疫苗(Ultravac®,Zoetis™)的接种方案:剂量依赖性有效性和长期免疫力评估。","authors":"Dan Gleser ,&nbsp;Michal Cohen ,&nbsp;Gabriel Kenigswald ,&nbsp;Maor Kedmi ,&nbsp;Benny Sharir ,&nbsp;Eyal Klement","doi":"10.1016/j.vaccine.2024.126531","DOIUrl":null,"url":null,"abstract":"<div><div>Bovine Ephemeral Fever (BEF) is an arthropod-borne virus (arbovirus) that presents a significant challenge to the cattle industry due to its economic impact<strong>,</strong> primarily through the loss of milk production in dairy cows. Vaccination is the predominant strategy for managing the disease. We recently showed a vaccine effectiveness (VE) of 60 % of a vaccine based on the Australian 919 BEFV isolate, with a natural challenge occurring shortly after the administration of the second dose of the vaccine. Still, there is a lack of data regarding the duration of protective immunity after vaccination and its potential enhancement after the administration of three and four vaccine doses. To answer these questions we conducted a retrospective cohort study of 850 cows (7 herds), analyzing the influence of different vaccination regimens on VE and a serosurvey of 71 cows to test the longevity of BEFV-specific serum-neutralizing antibodies (SNAb). We adopted a quantitative methodology for BEF diagnosis with the use of commercially validated precision dairy monitoring technologies for milk reduction identification. Survival analysis was used to analyze the vaccine dose effectiveness. A Cox regression mixed-effect model (COXME) was fitted to the data. The analysis demonstrated the following VE compared to zero vaccine doses: 82 % (<em>p</em>-value&lt;0.001) for four doses, 66 % (p-value&lt;0.026) for three doses and 39 % (p-value = 0.3) for two doses. Corroborating with the VE results, the four-dose regimen exhibited the highest geometric mean titer (GMT) value (4.45, CI<sub>95%</sub> = 3.99, 4.91), followed by the three-dose regimen (3.53, CI<sub>95%</sub> = 3.08,3.98), and the two-dose regimen (2.17, CI<sub>95%</sub> = 1.77,2.57). In light of these findings, we recommend vaccinating calves as early as four to six months old with two doses spaced one month apart, followed by a third and even fourth dose administered between six to 12 months later, ideally close to the onset of the high-risk season.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"43 ","pages":"Article 126531"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimizing protocols for the 919 strain-based bovine ephemeral fever virus vaccine (Ultravac®, Zoetis™): Evaluation of dose-dependent effectiveness and long-term immunity\",\"authors\":\"Dan Gleser ,&nbsp;Michal Cohen ,&nbsp;Gabriel Kenigswald ,&nbsp;Maor Kedmi ,&nbsp;Benny Sharir ,&nbsp;Eyal Klement\",\"doi\":\"10.1016/j.vaccine.2024.126531\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Bovine Ephemeral Fever (BEF) is an arthropod-borne virus (arbovirus) that presents a significant challenge to the cattle industry due to its economic impact<strong>,</strong> primarily through the loss of milk production in dairy cows. Vaccination is the predominant strategy for managing the disease. We recently showed a vaccine effectiveness (VE) of 60 % of a vaccine based on the Australian 919 BEFV isolate, with a natural challenge occurring shortly after the administration of the second dose of the vaccine. Still, there is a lack of data regarding the duration of protective immunity after vaccination and its potential enhancement after the administration of three and four vaccine doses. To answer these questions we conducted a retrospective cohort study of 850 cows (7 herds), analyzing the influence of different vaccination regimens on VE and a serosurvey of 71 cows to test the longevity of BEFV-specific serum-neutralizing antibodies (SNAb). We adopted a quantitative methodology for BEF diagnosis with the use of commercially validated precision dairy monitoring technologies for milk reduction identification. Survival analysis was used to analyze the vaccine dose effectiveness. A Cox regression mixed-effect model (COXME) was fitted to the data. The analysis demonstrated the following VE compared to zero vaccine doses: 82 % (<em>p</em>-value&lt;0.001) for four doses, 66 % (p-value&lt;0.026) for three doses and 39 % (p-value = 0.3) for two doses. Corroborating with the VE results, the four-dose regimen exhibited the highest geometric mean titer (GMT) value (4.45, CI<sub>95%</sub> = 3.99, 4.91), followed by the three-dose regimen (3.53, CI<sub>95%</sub> = 3.08,3.98), and the two-dose regimen (2.17, CI<sub>95%</sub> = 1.77,2.57). In light of these findings, we recommend vaccinating calves as early as four to six months old with two doses spaced one month apart, followed by a third and even fourth dose administered between six to 12 months later, ideally close to the onset of the high-risk season.</div></div>\",\"PeriodicalId\":23491,\"journal\":{\"name\":\"Vaccine\",\"volume\":\"43 \",\"pages\":\"Article 126531\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-11-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0264410X24012131\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X24012131","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

牛短暂热(BEF)是一种节肢动物传播的病毒(虫媒病毒),主要通过奶牛产奶量的损失对经济产生影响,因此给养牛业带来了巨大挑战。疫苗接种是控制该疾病的主要策略。我们最近的研究表明,基于澳大利亚 919 BEFV 分离物的疫苗有效率(VE)为 60%,第二剂疫苗接种后不久就会出现自然挑战。然而,关于接种疫苗后保护性免疫力的持续时间及其在接种三剂和四剂疫苗后增强的可能性,目前还缺乏相关数据。为了回答这些问题,我们对 850 头奶牛(7 个牧场)进行了回顾性队列研究,分析了不同疫苗接种方案对 VE 的影响,并对 71 头奶牛进行了血清调查,以检测 BEFV 特异性血清中和抗体 (SNAb) 的持久性。我们采用定量方法诊断 BEF,并使用经过商业验证的精确乳制品监测技术进行牛奶减少鉴定。我们采用了生存分析法来分析疫苗剂量的有效性。数据采用了 Cox 回归混合效应模型 (COXME)。分析表明,与零疫苗剂量相比,VE 值为82%(p-value95% = 3.99,4.91),其次是三剂方案(3.53,CI95% = 3.08,3.98)和两剂方案(2.17,CI95% = 1.77,2.57)。鉴于这些研究结果,我们建议在犊牛四到六个月大时就为其接种疫苗,两次接种间隔一个月,然后在六到十二个月后接种第三次甚至第四次疫苗,最好在接近高风险季节开始时接种。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Optimizing protocols for the 919 strain-based bovine ephemeral fever virus vaccine (Ultravac®, Zoetis™): Evaluation of dose-dependent effectiveness and long-term immunity
Bovine Ephemeral Fever (BEF) is an arthropod-borne virus (arbovirus) that presents a significant challenge to the cattle industry due to its economic impact, primarily through the loss of milk production in dairy cows. Vaccination is the predominant strategy for managing the disease. We recently showed a vaccine effectiveness (VE) of 60 % of a vaccine based on the Australian 919 BEFV isolate, with a natural challenge occurring shortly after the administration of the second dose of the vaccine. Still, there is a lack of data regarding the duration of protective immunity after vaccination and its potential enhancement after the administration of three and four vaccine doses. To answer these questions we conducted a retrospective cohort study of 850 cows (7 herds), analyzing the influence of different vaccination regimens on VE and a serosurvey of 71 cows to test the longevity of BEFV-specific serum-neutralizing antibodies (SNAb). We adopted a quantitative methodology for BEF diagnosis with the use of commercially validated precision dairy monitoring technologies for milk reduction identification. Survival analysis was used to analyze the vaccine dose effectiveness. A Cox regression mixed-effect model (COXME) was fitted to the data. The analysis demonstrated the following VE compared to zero vaccine doses: 82 % (p-value<0.001) for four doses, 66 % (p-value<0.026) for three doses and 39 % (p-value = 0.3) for two doses. Corroborating with the VE results, the four-dose regimen exhibited the highest geometric mean titer (GMT) value (4.45, CI95% = 3.99, 4.91), followed by the three-dose regimen (3.53, CI95% = 3.08,3.98), and the two-dose regimen (2.17, CI95% = 1.77,2.57). In light of these findings, we recommend vaccinating calves as early as four to six months old with two doses spaced one month apart, followed by a third and even fourth dose administered between six to 12 months later, ideally close to the onset of the high-risk season.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vaccine
Vaccine 医学-免疫学
CiteScore
8.70
自引率
5.50%
发文量
992
审稿时长
131 days
期刊介绍: Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信